Persistence of HIV-1 transmitted drug resistance mutations (Q37213028)

19 August 2017

Persistence of HIV-1 transmitted drug resistance mutations (English)

1 reference

19 August 2017

0 references

0 references

2

Deenan Pillay

1 reference

19 August 2017

6

Andrew Phillips

1 reference

19 August 2017

Hannah Castro

1

1 reference

19 August 2017

Patricia Cane

3

1 reference

19 August 2017

David Asboe

4

1 reference

19 August 2017

Valentina Cambiano

5

1 reference

19 August 2017

David T Dunn

7

1 reference

19 August 2017

UK Collaborative Group on HIV Drug Resistance

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

31 July 2013

1 reference

Journal of Infectious Diseases

19 August 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 August 2017

208

1 reference

19 August 2017

9

1 reference

19 August 2017

1459-1463

1 reference

Creative Commons Attribution 3.0 Unported

19 August 2017

start time

14 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Evolutionary pathways of transmitted drug-resistant HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Differential persistence of transmitted HIV-1 drug resistance mutation classes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Persistence of primary drug resistance among recently HIV-1 infected adults

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789571

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT345

Wide-band negative permeability of nonlinear metamaterials

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT345

Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23904291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIT345

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23904291

1 reference